Abnormalities, Multiple: Clinical Trials

3 trials for Abnormalities, Multiple, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Unknown 3

Follow Abnormalities, Multiple: new trials by email Literature Review of Abnormalities, Multiple trials Research Report on Abnormalities, Multiple

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Scientific Substantiation and Assessment of the Effectiveness of Pathogenetic Methods of Therapy for Congenital Ichthyosis in Children
Secukinumab Injection, Ustekinumab Injection, Dupilumab Injection - Congenital Ichthyosis
Phase 4UnknownNational Medical Research Center for Children's Health, Russian Federation502021-03-012021-08-09
Subacute Effect of Tolvaptan on Total Kidney Volume in Adult Patients With Autosomal Dominant Polycystic Kidney Disease
Tolvaptan - Autosomal Dominant Polycystic Kidney
Phase 4UnknownLisbet Brandi902018-09-122018-11-26
CCB Safety Study in Treatment of Hypertension of ADPKD
Candesartan, Candesartan and Cilnidipine, Candesartan plus non-CCB agents - Kidney, Polycystic, Autosomal Dominant
Phase 4UnknownKyorin University1502007-12-012007-10-18

Narrower conditions

Polycystic Kidney, Autosomal Dominant (2)  ·  Hypertension (1)  ·  Ichthyosis Vulgaris (1)  ·  Netherton Syndrome (1)

Broader conditions

Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Ciliopathies (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Kidney Diseases, Cystic (2)  ·  Male Urogenital Diseases (2)  ·  Polycystic Kidney Diseases (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Cardiovascular Diseases (1)  ·  Ichthyosiform Erythroderma, Congenital (1)

Interventions

Tolvaptan (1)  ·  Ustekinumab (1)  ·  candesartan (1)  ·  cilnidipine (1)  ·  dupilumab (1)  ·  secukinumab (1)

Sponsors

Kyorin University (1)  ·  Lisbet Brandi (1)  ·  National Medical Research Center for Children's Health, Russian Federation (1)

Countries

Denmark (1)  ·  Japan (1)  ·  Russia (1)

Top investigators

Eiji Higashihara, M.D. (1)  ·  Lisbet Brandi, MD DMSc MHM (1)

Results publications

PMID 18372389, PMID 39356039